ITI Limited has announced the successful receipt of listing approval from both the BSE Limited and the National Stock Exchange of India Limited. This approval pertains to the issuance of 19,65,029 equity shares of Rs. 10/- each, offered at a premium of Rs. 290.25/- per share. The shares were issued on a preferential basis to promoters, and the approvals are crucial for their formal listing and trading on the stock exchanges.
Stock Exchange Listing Approval Achieved
ITI Limited has officially announced that it has received listing approval from both the BSE Limited and the National Stock Exchange of India Limited (NSE) for its recent preferential issuance of equity shares. This significant development was communicated on June 11, 2026, and is a key step towards the formal admission of these shares for trading.
Details of the Preferential Issue
The approval covers a total of 19,65,029 equity shares, each with a face value of Rs. 10/-. These shares were issued at a premium of Rs. 290.25/- per share, bringing the total issue price to Rs. 300.25/-. The issuance was conducted on a preferential basis, specifically targeting the company’s promoters. The scrip codes for the respective exchanges are 523610 for BSE and ITI for NSE.
Exchange Approvals and Next Steps
The BSE granted its listing approval via a letter dated June 10, 2026 (Ref: LOD/PREF/MV/FIP/358/2026-27). Simultaneously, the NSE provided its in-principle approval on June 10, 2026 (Ref: NSE/LIST/53986), confirming the listing of these 19,65,029 equity shares allotted on a preferential basis.
Both exchanges have requested confirmation from the depositories (NSDL/CDSL) regarding the credit of shares to beneficiaries’ accounts before trading can commence. ITI Limited is required to ensure compliance with all relevant SEBI regulations and exchange guidelines, including the filing of shareholding patterns and any required trading approvals within stipulated timelines.
Source: BSE
